ARDELYX ($ARDX) posted quarterly earnings results on Thursday, October 30th. The company reported earnings of $0.00 per share, beating estimates of -$0.06 by $0.06. The company also reported revenue of $110,330,000, beating estimates of $102,895,641 by $7,434,359.
You can see Quiver Quantitative's $ARDX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ARDELYX Insider Trading Activity
ARDELYX insiders have traded $ARDX stock on the open market 19 times in the past 6 months. Of those trades, 4 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:
- DAVID M MOTT has made 4 purchases buying 881,377 shares for an estimated $3,403,196 and 0 sales.
- MICHAEL RAAB (President & CEO) has made 0 purchases and 3 sales selling 134,170 shares for an estimated $639,248.
- LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 4 sales selling 92,682 shares for an estimated $553,025.
- ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 17,815 shares for an estimated $101,034.
- MIKE KELLIHER (Chief Business Officer) has made 0 purchases and 2 sales selling 19,939 shares for an estimated $91,402.
- JUSTIN A RENZ (Chief Financial Officer) has made 0 purchases and 2 sales selling 14,255 shares for an estimated $71,200.
- ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,833 shares for an estimated $59,102.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ARDELYX Hedge Fund Activity
We have seen 113 institutional investors add shares of ARDELYX stock to their portfolio, and 100 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 9,919,066 shares (-39.7%) from their portfolio in Q2 2025, for an estimated $38,882,738
- MILLENNIUM MANAGEMENT LLC added 5,197,967 shares (+80.4%) to their portfolio in Q2 2025, for an estimated $20,376,030
- MARSHALL WACE, LLP added 2,866,843 shares (+34.2%) to their portfolio in Q2 2025, for an estimated $11,238,024
- BLACKROCK, INC. added 2,799,200 shares (+15.6%) to their portfolio in Q2 2025, for an estimated $10,972,864
- BANK OF AMERICA CORP /DE/ added 2,600,080 shares (+88.8%) to their portfolio in Q2 2025, for an estimated $10,192,313
- JONES FINANCIAL COMPANIES LLLP added 1,832,320 shares (+16861.3%) to their portfolio in Q2 2025, for an estimated $7,182,694
- JANE STREET GROUP, LLC removed 1,676,856 shares (-68.6%) from their portfolio in Q2 2025, for an estimated $6,573,275
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ARDELYX Government Contracts
We have seen $24,200 of award payments to $ARDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- XPHOZAH: $22,183
- XPHOZAH 30 MG: $2,016
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ARDELYX Analyst Ratings
Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/18/2025
To track analyst ratings and price targets for ARDELYX, check out Quiver Quantitative's $ARDX forecast page.
ARDELYX Price Targets
Multiple analysts have issued price targets for $ARDX recently. We have seen 4 analysts offer price targets for $ARDX in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Christopher Raymond from Piper Sandler set a target price of $9.0 on 08/06/2025
- Laura Chico from Wedbush set a target price of $14.0 on 08/05/2025
- Ryan Deschner from Raymond James set a target price of $12.0 on 08/05/2025
- Matthew Caufield from HC Wainwright & Co. set a target price of $10.0 on 06/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
